iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

With all the AI bubble headlines out there, it’s easy to conclude that the great bull run will end in tears and perhaps ...

On the selling side, ARK divested 38,338 shares of Palantir Technologies Inc (NYSE:PLTR) through its ARKK ETF, with the sale totaling $7,685,618. This marks a continuation of ARK’s recent reduction of ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

These healthcare stocks are making strides in very important ways. The healthcare industry revolves around constant innovation in areas like biotechnology, pharmaceuticals, medical devices, and ...